FR2430229A1 - Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation - Google Patents
Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparationInfo
- Publication number
- FR2430229A1 FR2430229A1 FR7801116A FR7801116A FR2430229A1 FR 2430229 A1 FR2430229 A1 FR 2430229A1 FR 7801116 A FR7801116 A FR 7801116A FR 7801116 A FR7801116 A FR 7801116A FR 2430229 A1 FR2430229 A1 FR 2430229A1
- Authority
- FR
- France
- Prior art keywords
- halo
- compsn
- pref
- phenoxy
- benzoyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
L'invention concerne de nouvelles compositions pour le traitement des hyperlipoprotéinémies et procédés de préparation. Selon l'invention, les compositions sont caractérisées en ce qu'elles contiennent en combinaison synergique un premier composé répondant à la formule ci-après :
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7801116A FR2430229A1 (fr) | 1978-01-16 | 1978-01-16 | Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7801116A FR2430229A1 (fr) | 1978-01-16 | 1978-01-16 | Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2430229A1 true FR2430229A1 (fr) | 1980-02-01 |
FR2430229B1 FR2430229B1 (fr) | 1983-07-01 |
Family
ID=9203505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7801116A Granted FR2430229A1 (fr) | 1978-01-16 | 1978-01-16 | Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2430229A1 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2162493A1 (fr) * | 1971-12-11 | 1973-07-20 | Merck Patent Gmbh |
-
1978
- 1978-01-16 FR FR7801116A patent/FR2430229A1/fr active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2162493A1 (fr) * | 1971-12-11 | 1973-07-20 | Merck Patent Gmbh |
Non-Patent Citations (1)
Title |
---|
EXBK/76 * |
Also Published As
Publication number | Publication date |
---|---|
FR2430229B1 (fr) | 1983-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8623557D0 (en) | Therapeutic agents | |
ATE108657T1 (de) | Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus. | |
MX9700081A (es) | Composiciones farmaceuticas de tacrina. | |
AU3044492A (en) | Sustained release thyroactive composition | |
BR122012014331B8 (pt) | formulações farmacêuticas | |
IL113967A0 (en) | Piperazine derivatives pharmaceutical compositionscontaining them and their preparation | |
HUT70426A (en) | Pyrazolo-pyrimidine derivatives, process for preparing them and pharmaceutical compositions containing them as active agents | |
IL117356A (en) | Controlled release matrix and pharmaceutical compositions for oral administration containing it | |
GR3019388T3 (en) | The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse | |
TW427902B (en) | Pharmaceutical composition for inhibiting low-density lipoprotein (LDL) oxidation and atherosclerosis | |
ES465906A1 (es) | Un procedimiento de preparacion de comprimidos | |
NZ225950A (en) | Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions | |
PH25585A (en) | Method for the treatment of osteoporosis, related disorders | |
FR2430229A1 (fr) | Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation | |
GR3025372T3 (en) | Use of l-carnitine and acyl l-carnitines for treating patients suffering from aids-related syndromes and asymptomatic hiv-seropositive patients | |
ES2000681A6 (es) | Un procedimiento para preparar nuevos compuestos de bencilpiperazina | |
DE3661311D1 (en) | Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them | |
ES8105691A1 (es) | Procedimiento para separar d-acido 2-(6-metoxi-2-naftil)- propionico de una mezcla de d-y 1-acidos 2-(6-metoxi-2-naf- til)-propionicos o sus sales | |
HUT66623A (en) | Process for preparing methanoanthracene derivatives and pharmaceutical compositions contg. them as active ingredient | |
JPS5551019A (en) | Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof | |
ATE204474T1 (de) | Amethocain enthaltende arzneimittel | |
ZA939153B (en) | Use of idazoxan and its derivatives for the preparation of a medicinal product intended for the treatment of parkinson's disease and its development | |
DE3380294D1 (en) | Pharmaceutical compositions in oral dosage form | |
DE3362876D1 (en) | Dibenzocycloheptenylidene compounds for use in modulating the immune response | |
JPS6442434A (en) | Gepilone for alleviating fright trouble |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CA | Change of address | ||
TP | Transmission of property | ||
ST | Notification of lapse |